Azacitidine injection 100mg “Ohhara”, manufactured by Ohara Pharmaceutical, contains Azacitidine. With YJ code 4291419D1042 and standard 100mg 1 bottle, it is used for the treatment of myelodysplastic syndrome and acute myeloid leukemia.
Azacitidine injection 100mg “Ohhara”
Need more detailed information?
Contact TASAKI PHARMA for inquiries about this medicine (English support available).
Contact us about this drug →